Core Viewpoint - The stock of Giant Bio (02367) has experienced a significant decline, dropping over 5% during trading, with a current price of HKD 37.62 and a trading volume of HKD 285 million [1] Group 1: Market Performance - As of the latest report, Giant Bio's stock is down 4.42% [1] - The company's main product, 可复美, has seen a drop in its ranking on Tmall's beauty list, falling from 5th place in 2023 to 20th place in the current year [1] - On Douyin, 可复美 has continuously fallen out of the top 20 since June of this year [1] Group 2: Sales and Revenue Trends - According to Citigroup's previous research, the promotional strategy for Giant Bio's products has become more stringent, leading to decreased price attractiveness [1] - Data from 蝉妈妈 indicates that from October 9 to 16, 可复美's Gross Merchandise Volume (GMV) on Douyin was between HKD 50 million to 75 million, a significant decline from over HKD 100 million during the same period last year [1]
巨子生物盘中跌超5% 旗下可复美今年双十一排名下滑